Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patients.

[1]  K. Shimada,et al.  Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[2]  B. Altura,et al.  Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: cross-talk among cytokines, Mg2+, NF-κB, and de novo ceramide. , 2012, American journal of physiology. Heart and circulatory physiology.

[3]  S. Wrenn,et al.  Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation. , 2011, Journal of colloid and interface science.

[4]  H. Völzke,et al.  Low serum magnesium concentrations predict cardiovascular and all-cause mortality. , 2011, Atherosclerosis.

[5]  B. Altura,et al.  Short-term magnesium deficiency upregulates sphingomyelin synthase and p53 in cardiovascular tissues and cells: relevance to the de novo synthesis of ceramide. , 2010, American journal of physiology. Heart and circulatory physiology.

[6]  A. Folsom,et al.  Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. , 2010, American heart journal.

[7]  B. Altura,et al.  Magnesium deficiency upregulates serine palmitoyl transferase (SPT 1 and SPT 2) in cardiovascular tissues: relationship to serum ionized Mg and cytochrome c. , 2010, American journal of physiology. Heart and circulatory physiology.

[8]  G. Burke,et al.  Association of Plasma Sphingomyelin Levels and Incident Coronary Heart Disease Events in an Adult Population: Multi-Ethnic Study of Atherosclerosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[9]  B. Altura,et al.  Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues. , 2009, American journal of physiology. Heart and circulatory physiology.

[10]  T. Honda,et al.  Specific, rapid, and sensitive enzymatic measurement of sphingomyelin, phosphatidylcholine and lysophosphatidylcholine in serum and lipid extracts. , 2008, Clinical biochemistry.

[11]  K. Williams,et al.  Acid Sphingomyelinase Promotes Lipoprotein Retention Within Early Atheromata and Accelerates Lesion Progression , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Kenji Kawasaki,et al.  Analysis of human serum lipoprotein lipid composition using MALDI-TOF mass spectrometry. , 2007, Annals of clinical and laboratory science.

[13]  M. Hojjati,et al.  Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine Published, JLR Papers in Press, December 21, 2005. , 2006, Journal of Lipid Research.

[14]  S. Blankenberg,et al.  Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease , 2006, Nutrition & metabolism.

[15]  M. Hojjati,et al.  Effect of Myriocin on Plasma Sphingolipid Metabolism and Atherosclerosis in apoE-deficient Mice* , 2005, Journal of Biological Chemistry.

[16]  M. Rekhter,et al.  Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice , 2004, Circulation.

[17]  Y. Soda,et al.  An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. , 2002, Clinical biochemistry.

[18]  P. Kinnunen,et al.  Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis? , 2002, Trends in cardiovascular medicine.

[19]  A. Tall,et al.  Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[20]  R. Rylander,et al.  Magnesium in drinking water in relation to morbidity and mortality from acute myocardial infarction. , 2000, Epidemiology.

[21]  B. Altura,et al.  Mg2+ modulates membrane sphingolipid and lipid second messenger levels in vascular smooth muscle cells , 1998, FEBS letters.

[22]  A. Tall,et al.  Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. , 1998, The Journal of clinical investigation.

[23]  K. Williams,et al.  Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pH , 1998, The Journal of Biological Chemistry.

[24]  K. Williams,et al.  Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. , 1996, The Journal of clinical investigation.

[25]  R. Barbour,et al.  Low extracellular magnesium induces intracellular free Mg deficits, ischemia, depletion of high-energy phosphates and cardiac failure in intact working rat hearts: a 31P-NMR study. , 1993, Biochimica et biophysica acta.

[26]  M. Eisenberg,et al.  Magnesium deficiency and sudden death. , 1992, American heart journal.

[27]  R. Barbour,et al.  Magnesium dietary intake modulates blood lipid levels and atherogenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Parl,et al.  Automated enzymatic measurement of lecithin, sphingomyelin, and phosphatidylglycerol in amniotic fluid. , 1987, Clinical chemistry.

[29]  Leary Wp.  Content of magnesium in drinking water and deaths from ischaemic heart disease in white South Africans. , 1986 .

[30]  M. D. De Buyzere,et al.  Enzymic assay for phosphatidylcholine and sphingomyelin in serum. , 1983, Clinical chemistry.

[31]  B. Chipperfield,et al.  RELATION OF MYOCARDIAL METAL CONCENTRATIONS TO WATER HARDNESS AND DEATH-RATES FROM ISCHÆMIC HEART DISEASE , 1979, The Lancet.

[32]  M. Takayama,et al.  A new enzymatic method for determination of serum choline-containing phospholipids. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[33]  J. Evans,et al.  High-performance liquid chromatography of phosphatidylcholine and sphingomyelin with detection in the region of 200 nm. , 1976, The Biochemical journal.

[34]  Y. Beyth,et al.  ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION , 1975, The Lancet.

[35]  Y. Marcel,et al.  Plasma phospholipids in the different types of primary hyperlipoproteinemia. , 1972, The Journal of laboratory and clinical medicine.

[36]  J. Dodge,et al.  Composition of phospholipids and of phospholipid fatty acids of human plasma. , 1967, Journal of lipid research.

[37]  P. Schneider.  Permanent sensitive stain for choline-containing phospholipids on thin-layer chromatograms. , 1966, Journal of lipid research.

[38]  D. B. Zilversmit,et al.  The Synthesis of Phospholipids in Human Atheromatous Lesions , 1961, Circulation.

[39]  E. Smith,et al.  Intimal and medial lipids in human aortas. , 1960, Lancet.